Drug archive
Aminobenzoate Potassium (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antifibrotic
Description
Aminobenzoate potassium (a-mee-noe-BEN-zoe-ate poe-TAS-ee-um) is used to treat fibrosis, a condition in which the skin and underlying tissues tighten and become less flexible. This condition occurs in such diseases as dermatomyositis, morphea, Peyronie's disease, scleroderma, and linear scleroderma.
Aminobenzoate potassium is also used to treat a certain type of inflammation (nonsuppurative inflammation) that occurs in such diseases as dermatomyositis, pemphigus, and Peyronie's disease.
This medicine is available only with your doctor's prescription in the following dosage forms:
- Capsules (U.S. and Canada)
- Powder for oral solution (U.S. and Canada)
- Tablets (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Potaba
- Potaba Envules
- Potaba Powder
In Canada -
- Potaba
- Potaba Envules
- Potaba Powder
Other commonly used names are KPAB , potassium aminobenzoate , and potassium para-aminobenzoate .